FDA Inspection 1150702 — Zhejiang Huahai Pharmaceutical
The FDA completed an inspection of Zhejiang Huahai Pharmaceutical on July 29, 2021 in Linhai. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 29, 2021
- Fiscal Year
- 2021
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Linhai (China)